Webinar: Lighten Up! Long-term imaging with ultra-bright, organic AIE cell trackers

 

 What Does it Cover?

With the recent discovery of a special class of organic compounds with aggregation-induced emission (AIE) characteristics, new opportunities have opened for in vitro and in vivo imaging. AIE compounds are now available as organic ultrabright LuminiCell Nanoparticles that enable long-term cell tracking and imaging for applications such as cancer research and stem cell biology.
 

 What Will You Learn?

  • Learn how aggregation-induced emission (AIE) enables a new class of reagents for in vitro and in vivo imaging
  • Discover how ultra-bright organic nanoparticles can be used for long-term cell tracking using image-based techniques

 Who Should Attend?

  • Cell biologists
  • Stem cell researchers
  • Cancer biologists
  • Anyone seeking new reagents and methods for live-cell imaging

 

Speaker Bio
Liu Bin, PhD
Department Head
Department of Chemical and Biomolecular Engineering
National University of Singapore
Named among the World's Most Influential Minds and the Top 1% Highly Cited Researchers in Materials Science by Thomson Reuters, Professor Liu specializes in bringing organic soluble materials into aqueous media, with a focus on the exploration of their unique applications in biomedical research, environmental monitoring and electronic devices. A recipient of multiple prestigious awards including the L'Oreal Women in Science National Fellowship, Asia Rising Star, Singapore National Institute of Chemistry-BASF Materials Award, Singapore National Research Foundation lnvestigatorship, Elsevier Materials in Society Lectureship, NUS Provost's Chair Professorship and the President's Technology Award, Professor Liu was recently elected as Fellow of the Royal Society of Chemistry, Fellow of Singapore Academy of Engineering and Asia-Pacific Academy of Materials, in addition to invitations to serve on editorial boards of 15 international refereed journals. Dr Liu holds 28 patents, of which 15 are licensed to companies across the US, UK and Asia, and co-founded a start-up company Luminicell to commercialize her bioprobe technology based on fluorogens with aggregation-induced emission.